P1.16-01 Amivantamab and Lazertinib in Treatment-Naive EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
September 1, 2022
Cited by 7

Abstract


Related Papers

No related papers found

Powered by citation graph analysis